Antonio Medina de Almeida
AuthID: R-000-T91
21
TITLE: The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe
AUTHORS: Jose Tomas Navarro; Gunnar Birgegard; Janet Strivens; Wietske W G Hollegien; Naomi van Hattem; Manon T Saris; Marielle J Wondergem; Cheng Hock Toh; Antonio M Almeida;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 5
AUTHORS: Jose Tomas Navarro; Gunnar Birgegard; Janet Strivens; Wietske W G Hollegien; Naomi van Hattem; Manon T Saris; Marielle J Wondergem; Cheng Hock Toh; Antonio M Almeida;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 5
INDEXED IN: Scopus WOS
22
TITLE: Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available
AUTHORS: Foltz, L; Pica, GM; Zerazhi, H; Van Droogenbroeck, J; Visanica, S; de la Fuente, EB; Leber, B; de Almeida, AM; Ranta, D; Kiladjian, JJ; Chrit, L; Kandra, A; Morando, J; Devos, T;
PUBLISHED: 2019, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 60, ISSUE: 14
AUTHORS: Foltz, L; Pica, GM; Zerazhi, H; Van Droogenbroeck, J; Visanica, S; de la Fuente, EB; Leber, B; de Almeida, AM; Ranta, D; Kiladjian, JJ; Chrit, L; Kandra, A; Morando, J; Devos, T;
PUBLISHED: 2019, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 60, ISSUE: 14
23
TITLE: Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies
AUTHORS: Ulrich Germing; Ester N Oliva; Devendra Hiwase; Antonio Almeida;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 6
AUTHORS: Ulrich Germing; Ester N Oliva; Devendra Hiwase; Antonio Almeida;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 6
INDEXED IN: Scopus WOS
24
TITLE: Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial
AUTHORS: Guillermo Garcia-Manero; Antonio Almeida; Pierre Fenaux; Norbert Gattermann; Aristoteles Giagounidis; Stuart L Goldberg; Keiya Ozawa; Jerry Weaver; Valeria Santini;
PUBLISHED: 2019, SOURCE: Clinical Lymphoma Myeloma and Leukemia, VOLUME: 19, ISSUE: 4
AUTHORS: Guillermo Garcia-Manero; Antonio Almeida; Pierre Fenaux; Norbert Gattermann; Aristoteles Giagounidis; Stuart L Goldberg; Keiya Ozawa; Jerry Weaver; Valeria Santini;
PUBLISHED: 2019, SOURCE: Clinical Lymphoma Myeloma and Leukemia, VOLUME: 19, ISSUE: 4
25
TITLE: Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms
AUTHORS: Bruno A Cardoso; Teresa L Ramos; Hélio Belo; Filipe Vilas-Boas; Carla Real; António M Almeida;
PUBLISHED: 2019, SOURCE: Experimental Hematology, VOLUME: 72
AUTHORS: Bruno A Cardoso; Teresa L Ramos; Hélio Belo; Filipe Vilas-Boas; Carla Real; António M Almeida;
PUBLISHED: 2019, SOURCE: Experimental Hematology, VOLUME: 72
26
TITLE: Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS Full Text
AUTHORS: Louise de Swart; Alex Smith; Detlef Haase; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Guillermo Sanz; Reinhard Stauder; Moshe Mittelman; Eva Hellstrom Lindberg; Luca Malcovati; Saskia Langemeijer; Mette Skov Holm; Krzysztof Madry; Ulrich Germing; Antonio Medina Almeida; Aurelia Tatic; Aleksandar Savic; Njetocka Gredelj Simec; Corine van Marrewijk; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
AUTHORS: Louise de Swart; Alex Smith; Detlef Haase; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Guillermo Sanz; Reinhard Stauder; Moshe Mittelman; Eva Hellstrom Lindberg; Luca Malcovati; Saskia Langemeijer; Mette Skov Holm; Krzysztof Madry; Ulrich Germing; Antonio Medina Almeida; Aurelia Tatic; Aleksandar Savic; Njetocka Gredelj Simec; Corine van Marrewijk; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
INDEXED IN: Scopus WOS
27
TITLE: Hematology traning in Europe
AUTHORS: Almeida, A;
PUBLISHED: 2018, SOURCE: International Journal of Laboratory Hematology, VOLUME: 40, ISSUE: S1
AUTHORS: Almeida, A;
PUBLISHED: 2018, SOURCE: International Journal of Laboratory Hematology, VOLUME: 40, ISSUE: S1
28
TITLE: Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient–Physician Perspective
AUTHORS: Saglio, G; Sharf, G; Almeida, A; Bogdanovic, A; Bombaci, F; Čugurović, J; Deekes, N; Garcia Gutiérrez, V; de Jong, J; Narbutas, Š; Westerweel, P; Zackova, D;
PUBLISHED: 2018, SOURCE: Clinical Lymphoma, Myeloma and Leukemia, VOLUME: 18, ISSUE: 6
AUTHORS: Saglio, G; Sharf, G; Almeida, A; Bogdanovic, A; Bombaci, F; Čugurović, J; Deekes, N; Garcia Gutiérrez, V; de Jong, J; Narbutas, Š; Westerweel, P; Zackova, D;
PUBLISHED: 2018, SOURCE: Clinical Lymphoma, Myeloma and Leukemia, VOLUME: 18, ISSUE: 6
29
TITLE: Should more MDS patients be treated with immune-suppression?
AUTHORS: Almeida, A;
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 71
AUTHORS: Almeida, A;
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 71
30
TITLE: Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia
AUTHORS: Ball, B; Komrokji, RS; Ades, L; Sekeres, MA; DeZern, AE; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, SD; Fenaux, P; Prebet, T;
PUBLISHED: 2018, SOURCE: BLOOD ADVANCES, VOLUME: 2, ISSUE: 16
AUTHORS: Ball, B; Komrokji, RS; Ades, L; Sekeres, MA; DeZern, AE; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, SD; Fenaux, P; Prebet, T;
PUBLISHED: 2018, SOURCE: BLOOD ADVANCES, VOLUME: 2, ISSUE: 16